Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02567240 · ClinicalTrials.gov registry record · Phase 1
Carbon Monoxide-Saturated Medium for Islet Isolation
A Phase 1 study of Chronic Pancreatitis, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 1
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT02567240: Completed Phase 1 study of Chronic Pancreatitis, sponsored by Medical University of South Carolina.
NCT02567240 is a Phase 1 study of Chronic Pancreatitis that has completed, run by Medical University of South Carolina. The registered enrollment target is 16 participants, below the 689-participant average among 42 other Chronic Pancreatitis trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02567240, a Phase 1 study of Chronic Pancreatitis, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to determine whether harvesting islets using carbon monoxide (CO)-saturated mediums can protect islet cell from death after autologous islet transplantation in patients with chronic pancreatitis.
Conditions Studied
Interventions
- OTHER Carbon monoxide-bubbled mediums
Study Locations (1)
South Carolina
- GI Surgery, Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2015-01 |
| Est. Completion | 2018-12 |
| Phase | Phase 1 |
What the finished NCT02567240 record still lists
NCT02567240 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 689-participant average among 42 other Chronic Pancreatitis trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Chronic Pancreatitis appearing as the primary indexed condition, and to 1 intervention - of which Carbon monoxide-bubbled mediums is the first listed.
NCT02567240 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT02567240 about?
NCT02567240 is a clinical study titled "Carbon Monoxide-Saturated Medium for Islet Isolation". The goal of this study is to determine whether harvesting islets using carbon monoxide (CO)-saturated mediums can protect islet cell from death after autologous islet transplantation in patients with chronic pancreatitis.
What is the current status of trial NCT02567240?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2015-01. Estimated completion is 2018-12.
What conditions does trial NCT02567240 study?
This clinical trial studies the following conditions: Chronic Pancreatitis.
What interventions are being tested in trial NCT02567240?
The interventions under investigation include: Carbon monoxide-bubbled mediums (OTHER).
Who is sponsoring clinical trial NCT02567240?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02567240 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pancreatitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02567240's enrollment target sits among peer trials
16 38th of 42 higher than 5 of 42 other Chronic Pancreatitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Pancreatitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Autologous Mesenchymal Stromal Cells and Islet Co-transplantation in TP-IAT
RECRUITING · Phase 1
-
Novel Cellular Therapy for the Treatment of Pain Associated With Chronic Pancreatitis
RECRUITING · Phase 1
-
Soy Tomato Juice to Improve Outcomes in Pancreatitis
RECRUITING · Phase 1
-
STTEPP: Safety, Tolerability and Dose Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis
RECRUITING · Phase 1
-
Trial of Indomethacin in Chronic Pancreatitis
COMPLETED · Phase 1
-
Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia